TCR2 Therapeutics Q1 EPS $(1.03) Down From $(0.76) YoY

Benzinga · 05/11/2023 10:46
TCR2 Therapeutics (NASDAQ:TCRR) reported quarterly losses of $(1.03) per share. This is a 35.53 percent decrease over losses of $(0.76) per share from the same period last year.